Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Elizabeth McFarland

Concepts (375)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
48
2025
2701
2.960
Why?
HIV-1
26
2025
836
2.950
Why?
Respiratory Syncytial Virus Vaccines
6
2022
34
2.410
Why?
Respiratory Syncytial Virus Infections
6
2022
119
2.220
Why?
Respiratory Syncytial Virus, Human
6
2022
68
2.200
Why?
Infectious Disease Transmission, Vertical
18
2025
170
2.190
Why?
HIV Antibodies
12
2025
57
2.100
Why?
Anti-Retroviral Agents
12
2023
230
1.780
Why?
Viral Proteins
3
2020
321
1.630
Why?
Antibodies, Viral
8
2022
601
1.160
Why?
Antibodies, Neutralizing
8
2025
263
1.140
Why?
Antibodies, Monoclonal
6
2025
1355
0.910
Why?
Anti-HIV Agents
11
2025
747
0.900
Why?
AIDS Vaccines
8
2018
47
0.880
Why?
Pregnancy Complications, Infectious
8
2016
364
0.790
Why?
Gene Deletion
2
2020
370
0.750
Why?
Breast Feeding
4
2025
422
0.670
Why?
Atazanavir Sulfate
2
2017
41
0.660
Why?
HIV Protease Inhibitors
2
2017
62
0.640
Why?
Ritonavir
2
2017
72
0.630
Why?
Infant, Newborn
23
2025
5687
0.600
Why?
Vaccination
6
2020
1346
0.600
Why?
Vaccines, Attenuated
6
2022
126
0.590
Why?
HIV Envelope Protein gp120
6
2017
57
0.590
Why?
Infant
31
2025
8914
0.530
Why?
Nelfinavir
1
2016
9
0.520
Why?
Lopinavir
1
2016
30
0.510
Why?
Syncope
1
2016
50
0.510
Why?
Patient Dropouts
1
2016
64
0.510
Why?
Bradycardia
1
2016
53
0.500
Why?
Lyme Disease
1
2016
50
0.500
Why?
Health Resources
1
2016
112
0.480
Why?
Infant, Newborn, Diseases
1
2016
108
0.460
Why?
HIV
5
2014
225
0.430
Why?
Patient Compliance
2
2018
560
0.410
Why?
Child
37
2025
20655
0.400
Why?
Immunogenicity, Vaccine
4
2021
27
0.400
Why?
CD4-Positive T-Lymphocytes
2
2017
1046
0.370
Why?
T-Lymphocytes, Cytotoxic
4
2005
168
0.370
Why?
Humans
72
2025
128418
0.370
Why?
Virus Replication
4
2020
444
0.370
Why?
Female
48
2025
68154
0.360
Why?
Lymphocyte Activation
5
2017
1098
0.320
Why?
Male
39
2025
62858
0.320
Why?
Adolescent
27
2025
20179
0.300
Why?
Viral Load
9
2017
450
0.290
Why?
HIV Seropositivity
2
2023
119
0.280
Why?
Bone Density
2
2025
474
0.280
Why?
Double-Blind Method
3
2020
1848
0.270
Why?
RNA, Viral
8
2023
616
0.270
Why?
Antibodies, Bacterial
2
2018
135
0.250
Why?
Antiretroviral Therapy, Highly Active
6
2017
266
0.240
Why?
Dyslipidemias
2
2017
176
0.240
Why?
Bone Development
1
2025
49
0.240
Why?
Immunoenzyme Techniques
1
2005
206
0.230
Why?
Immunoglobulin G
3
2022
843
0.230
Why?
Colonography, Computed Tomographic
1
2024
6
0.220
Why?
Viremia
3
2011
130
0.220
Why?
Diverticulum
1
2024
11
0.220
Why?
Child, Preschool
21
2022
10384
0.220
Why?
Gene Products, gag
2
1994
36
0.220
Why?
Mammography
1
2025
146
0.220
Why?
Young Adult
12
2021
12312
0.210
Why?
Pregnancy
11
2023
6357
0.210
Why?
Squalene
3
2017
7
0.210
Why?
Complementarity Determining Regions
1
2002
49
0.200
Why?
Drug Resistance, Viral
2
2016
110
0.190
Why?
CD4 Lymphocyte Count
4
2017
267
0.190
Why?
Half-Life
1
2021
143
0.190
Why?
Growth Differentiation Factor 15
1
2021
39
0.190
Why?
Mitochondrial Diseases
1
2021
88
0.180
Why?
Immunization Schedule
2
2018
198
0.180
Why?
T-Lymphocytes
2
2009
1923
0.180
Why?
Drug Therapy, Combination
4
2017
1009
0.180
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
334
0.170
Why?
Fibroblast Growth Factors
1
2021
170
0.170
Why?
RNA, Small Untranslated
1
2020
15
0.170
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
15
0.170
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
184
0.160
Why?
Cytokines
2
2021
1983
0.160
Why?
Body Temperature
1
2020
212
0.160
Why?
Point Mutation
1
2020
223
0.160
Why?
Insulin Resistance
3
2019
1164
0.150
Why?
Immunologic Memory
2
2021
341
0.150
Why?
Haemophilus Vaccines
2
2018
28
0.150
Why?
Immunocompromised Host
2
2000
194
0.150
Why?
Metabolic Syndrome
1
2021
338
0.150
Why?
CD8-Positive T-Lymphocytes
2
2011
846
0.140
Why?
Darunavir
1
2017
17
0.140
Why?
Interleukin-12
1
1998
119
0.140
Why?
Dose-Response Relationship, Drug
1
2021
1936
0.140
Why?
Therapeutic Equipoise
1
2017
2
0.140
Why?
Mycobacterium Infections, Nontuberculous
2
2012
354
0.140
Why?
Interferon-gamma
5
2012
759
0.140
Why?
Uganda
1
2017
72
0.140
Why?
Antibody Formation
1
2018
288
0.140
Why?
Lymphopoiesis
1
2017
26
0.140
Why?
Immunoglobulin A
2
2017
201
0.140
Why?
High-Throughput Screening Assays
1
2018
134
0.140
Why?
Receptors, CCR5
1
2017
57
0.130
Why?
CD4-CD8 Ratio
1
2016
22
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
12
0.130
Why?
Cohort Studies
8
2025
5388
0.130
Why?
Adoption
1
2016
32
0.130
Why?
Mothers
3
2017
729
0.130
Why?
Virus Latency
1
2016
77
0.130
Why?
Adult
15
2023
35300
0.120
Why?
Continuity of Patient Care
1
2018
275
0.120
Why?
Chickenpox Vaccine
1
2015
71
0.120
Why?
Early Diagnosis
1
2016
234
0.120
Why?
Body Height
2
2017
192
0.120
Why?
Zimbabwe
2
2025
54
0.120
Why?
Gene Products, env
1
1994
6
0.120
Why?
Disease Susceptibility
1
2017
331
0.120
Why?
Haemophilus influenzae type b
1
2014
10
0.120
Why?
Bacterial Capsules
1
2014
28
0.120
Why?
Chickenpox
1
2015
78
0.120
Why?
Antibody Affinity
1
2014
59
0.120
Why?
South Africa
2
2025
192
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
222
0.110
Why?
Cote d'Ivoire
2
2025
9
0.110
Why?
Parotitis
1
2014
6
0.110
Why?
Vaccines, Synthetic
4
2005
126
0.110
Why?
Developing Countries
1
2016
285
0.110
Why?
Lipids
1
2017
620
0.110
Why?
Puberty, Delayed
1
2013
5
0.110
Why?
Cytotoxicity, Immunologic
3
2002
218
0.110
Why?
Intestines
1
2017
344
0.110
Why?
Leukocytes, Mononuclear
4
2013
539
0.110
Why?
Retrospective Studies
8
2023
14454
0.110
Why?
Vaccines
1
2018
393
0.100
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
Why?
Mycobacterium chelonae
1
1993
8
0.100
Why?
Patient Selection
1
2017
663
0.100
Why?
Breast Neoplasms
1
2025
2132
0.100
Why?
Mitochondria
2
2021
848
0.100
Why?
Lamivudine
3
2023
61
0.100
Why?
Cell Movement
1
2017
936
0.100
Why?
Child Development
1
2017
452
0.100
Why?
Clinical Trials as Topic
1
2017
993
0.100
Why?
Pediatric Obesity
1
2019
570
0.100
Why?
Cardiovascular Diseases
2
2016
1999
0.100
Why?
STAT1 Transcription Factor
1
2012
70
0.100
Why?
Prospective Studies
4
2017
7036
0.100
Why?
Body Weight
2
2017
928
0.090
Why?
Polysorbates
3
2017
38
0.090
Why?
Body Fat Distribution
1
2011
49
0.090
Why?
Mycobacterium avium Complex
1
2012
86
0.090
Why?
Epitopes
2
2022
466
0.090
Why?
United States
9
2023
13830
0.090
Why?
Cost-Benefit Analysis
2
2025
568
0.090
Why?
Biomedical Research
1
2017
635
0.090
Why?
Research Design
1
2017
1036
0.090
Why?
Interleukin-2
2
2003
434
0.080
Why?
Respiratory Tract Infections
1
2014
372
0.080
Why?
Exercise
1
2021
1929
0.080
Why?
Prenatal Exposure Delayed Effects
1
2016
563
0.080
Why?
Freezing
1
2009
86
0.080
Why?
Absorptiometry, Photon
2
2025
248
0.080
Why?
Blood
1
2009
99
0.080
Why?
Algorithms
1
2016
1618
0.080
Why?
Staff Development
1
2009
57
0.080
Why?
Age Factors
4
2019
3103
0.080
Why?
Phenotype
1
2017
3044
0.070
Why?
Biomarkers
4
2021
3880
0.070
Why?
T-Lymphocyte Subsets
2
2002
409
0.070
Why?
Longitudinal Studies
3
2025
2710
0.070
Why?
Specimen Handling
1
2009
164
0.070
Why?
Lymphocyte Subsets
2
2009
85
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
815
0.070
Why?
Faculty
1
2009
136
0.070
Why?
Withholding Treatment
1
2008
70
0.070
Why?
Adipose Tissue
1
2011
589
0.070
Why?
Enterovirus A, Human
1
2007
12
0.070
Why?
Polymerase Chain Reaction
4
2011
1020
0.070
Why?
Central Nervous System Viral Diseases
1
2007
73
0.060
Why?
Flow Cytometry
3
2009
1142
0.060
Why?
DNA, Viral
2
2000
348
0.060
Why?
Academic Medical Centers
1
2009
476
0.060
Why?
False Negative Reactions
1
2025
51
0.060
Why?
Isoantigens
1
1984
12
0.060
Why?
Cell Line
3
2012
2731
0.060
Why?
Medical Audit
1
2025
77
0.060
Why?
Enterovirus Infections
1
2007
171
0.060
Why?
C-Reactive Protein
2
2021
397
0.060
Why?
Colorado
3
2023
4375
0.060
Why?
Immunity, Cellular
1
2006
263
0.060
Why?
Disease Outbreaks
1
2007
341
0.060
Why?
Follow-Up Studies
3
2021
4892
0.060
Why?
Linear Models
2
2020
813
0.060
Why?
Confusion
1
2024
27
0.050
Why?
Comorbidity
2
2021
1543
0.050
Why?
Sequence Analysis, DNA
2
2007
771
0.050
Why?
Thymus Gland
1
1984
309
0.050
Why?
Risk Factors
4
2021
9704
0.050
Why?
Tablets
1
2023
34
0.050
Why?
Constriction, Pathologic
1
2024
228
0.050
Why?
Regression Analysis
2
2021
978
0.050
Why?
Respiratory Syncytial Viruses
1
2022
52
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
21
0.050
Why?
Immunophenotyping
2
1994
311
0.050
Why?
Zidovudine
2
2015
77
0.050
Why?
Clone Cells
1
2002
255
0.050
Why?
Dose-Response Relationship, Immunologic
1
2001
81
0.050
Why?
Cough
1
2022
116
0.050
Why?
Emtricitabine
1
2023
168
0.050
Why?
Vaccines, Subunit
1
2001
47
0.050
Why?
Pyridones
1
2023
159
0.050
Why?
Tenofovir
1
2023
231
0.050
Why?
Lung
1
2014
3743
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
50
0.040
Why?
Public Health Surveillance
1
2021
67
0.040
Why?
Ganciclovir
1
2000
50
0.040
Why?
Computer Simulation
1
2005
939
0.040
Why?
Adjuvants, Immunologic
2
2017
221
0.040
Why?
Africa
1
2020
98
0.040
Why?
Cross-Sectional Studies
3
2021
5039
0.040
Why?
Injections, Subcutaneous
1
2020
144
0.040
Why?
Sex Factors
2
2019
1945
0.040
Why?
Diagnostic Tests, Routine
1
2021
101
0.040
Why?
Symptom Assessment
1
2021
126
0.040
Why?
HIV Seronegativity
1
2019
25
0.040
Why?
HLA-D Antigens
1
1999
34
0.040
Why?
Risk
1
2021
853
0.040
Why?
Case-Control Studies
2
2019
3328
0.040
Why?
Prevalence
2
2016
2547
0.040
Why?
Cytomegalovirus Infections
1
2000
185
0.040
Why?
Hospitals
1
2023
631
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
48
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
42
0.040
Why?
Vaccines, Combined
1
2018
48
0.040
Why?
Cholesterol, HDL
1
2019
203
0.040
Why?
Amino Acid Sequence
1
2002
2040
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
Why?
Mutation
3
2018
3689
0.040
Why?
Odds Ratio
1
2021
1023
0.040
Why?
Hepatitis B Vaccines
1
2018
47
0.040
Why?
Drug Resistance, Microbial
2
2000
64
0.040
Why?
Molecular Sequence Data
1
2002
2819
0.040
Why?
Nutrition Surveys
1
2019
261
0.040
Why?
Case Management
1
2018
64
0.040
Why?
Antigens, Viral
1
1998
174
0.040
Why?
Cholesterol
1
2019
406
0.030
Why?
Cholesterol, LDL
1
2019
360
0.030
Why?
Reproducibility of Results
1
2005
3020
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
185
0.030
Why?
Disease Management
1
2021
587
0.030
Why?
Treatment Adherence and Compliance
1
2017
23
0.030
Why?
Immune Tolerance
1
1999
349
0.030
Why?
Triglycerides
1
2019
523
0.030
Why?
Lymphocyte Count
2
2009
150
0.030
Why?
Cell Division
1
1998
778
0.030
Why?
Uncertainty
1
2017
114
0.030
Why?
Treatment Failure
1
2017
339
0.030
Why?
Multicenter Studies as Topic
1
2017
285
0.030
Why?
Nevirapine
1
2015
16
0.030
Why?
Time-to-Treatment
1
2017
179
0.030
Why?
Seroepidemiologic Studies
1
2015
155
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1356
0.030
Why?
Maternal Exposure
1
2017
175
0.030
Why?
Patient Outcome Assessment
1
2016
125
0.030
Why?
Malnutrition
1
2016
79
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Antiviral Agents
1
2000
703
0.030
Why?
Treatment Outcome
2
2021
10152
0.030
Why?
Coinfection
1
2016
131
0.030
Why?
Neutropenia
1
2015
134
0.030
Why?
Vaccines, Conjugate
1
2014
63
0.030
Why?
Counseling
1
2018
382
0.030
Why?
Sexual and Gender Minorities
1
2018
193
0.030
Why?
Global Health
1
2017
327
0.030
Why?
Cells, Cultured
2
2008
4001
0.030
Why?
Anemia
1
2015
160
0.030
Why?
Maternal-Fetal Exchange
1
2014
161
0.030
Why?
Electron Transport Complex IV
1
2013
57
0.030
Why?
Electron Transport Complex I
1
2013
38
0.030
Why?
Thrombocytopenia
1
2015
181
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
Why?
HIV Reverse Transcriptase
1
1993
30
0.030
Why?
Radiography, Thoracic
1
2014
164
0.030
Why?
CD8 Antigens
1
1993
76
0.030
Why?
Severity of Illness Index
1
2021
2722
0.030
Why?
CD3 Complex
1
1993
101
0.030
Why?
Drug Administration Schedule
2
2008
751
0.030
Why?
Lymphocytes
1
1994
367
0.020
Why?
Oxidative Phosphorylation
1
2013
184
0.020
Why?
Medication Adherence
1
2017
560
0.020
Why?
DNA, Mitochondrial
1
2013
188
0.020
Why?
Blood Pressure
1
2019
1728
0.020
Why?
Blood Transfusion
1
1994
290
0.020
Why?
P-Selectin
1
2011
26
0.020
Why?
Antigens, CD
1
1994
482
0.020
Why?
E-Selectin
1
2011
53
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Tuberculosis, Pulmonary
1
1993
135
0.020
Why?
Chemokine CCL2
1
2011
118
0.020
Why?
Hospitalization
1
2021
2057
0.020
Why?
Cell Proliferation
2
2009
2344
0.020
Why?
Hyperlipidemias
1
2011
126
0.020
Why?
Fibrinogen
1
2011
158
0.020
Why?
Protein Multimerization
1
2012
178
0.020
Why?
Cross Infection
1
1993
195
0.020
Why?
Interferon-alpha
1
2012
192
0.020
Why?
Cell Adhesion Molecules
1
2011
172
0.020
Why?
Nontuberculous Mycobacteria
1
1993
204
0.020
Why?
Healthcare Disparities
1
2017
579
0.020
Why?
Infant, Premature
1
1994
535
0.020
Why?
Diagnosis, Differential
1
2014
1416
0.020
Why?
Pokeweed Mitogens
1
2009
7
0.020
Why?
L-Selectin
1
2009
24
0.020
Why?
Human Experimentation
1
2009
12
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
33
0.020
Why?
Leukocyte Common Antigens
1
2009
81
0.020
Why?
Obesity
1
2021
2858
0.020
Why?
Multivariate Analysis
1
2011
1484
0.020
Why?
Meningitis, Aseptic
1
2007
13
0.020
Why?
Virus Cultivation
1
2007
28
0.020
Why?
Interleukin-6
1
2011
716
0.020
Why?
Phosphorylation
1
2012
1681
0.020
Why?
Data Interpretation, Statistical
1
2009
335
0.020
Why?
Pregnancy Outcome
1
2010
389
0.020
Why?
Cerebrospinal Fluid
1
2007
88
0.020
Why?
Multiple Organ Failure
1
2007
120
0.020
Why?
Paralysis
1
2007
71
0.020
Why?
B-Lymphocytes
1
2012
817
0.020
Why?
Kinetics
1
2010
1615
0.020
Why?
Respiratory System
1
2007
152
0.020
Why?
Genotype
1
2011
1828
0.020
Why?
Immunoglobulin A, Secretory
1
2005
8
0.020
Why?
Cell Survival
1
2009
1077
0.020
Why?
Phosphates
1
1987
168
0.020
Why?
Muscles
1
1987
322
0.020
Why?
Encephalitis
1
2007
132
0.020
Why?
Gastrointestinal Tract
1
2007
182
0.010
Why?
Mucous Membrane
1
2005
120
0.010
Why?
Chemistry, Physical
1
1984
37
0.010
Why?
Antigen-Antibody Reactions
1
1984
51
0.010
Why?
Chemical Phenomena
1
1984
80
0.010
Why?
DNA-Binding Proteins
1
2012
1421
0.010
Why?
Myasthenia Gravis
1
1984
21
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
62
0.010
Why?
Saliva
1
2005
207
0.010
Why?
Tomography, X-Ray Computed
1
2014
2523
0.010
Why?
Tissue Distribution
1
1984
291
0.010
Why?
Aging
2
2003
1750
0.010
Why?
Blood Glucose
1
2013
2093
0.010
Why?
Epithelium
1
1984
306
0.010
Why?
Middle Aged
2
2020
30889
0.010
Why?
Body Mass Index
1
2011
2261
0.010
Why?
Anti-Bacterial Agents
1
1993
1663
0.010
Why?
Infusions, Intravenous
1
2003
385
0.010
Why?
Reference Values
1
2003
776
0.010
Why?
Mice, Inbred BALB C
1
1984
1228
0.010
Why?
Suspensions
1
2000
32
0.010
Why?
Capsules
1
2000
37
0.010
Why?
Urban Population
1
2003
440
0.010
Why?
Drug Tolerance
1
2000
83
0.010
Why?
Cytomegalovirus
1
2000
152
0.010
Why?
Signal Transduction
1
2012
4826
0.010
Why?
Administration, Oral
1
2000
754
0.010
Why?
Epithelial Cells
1
1984
1032
0.010
Why?
Immunization
1
2000
412
0.010
Why?
Time Factors
1
2008
6482
0.010
Why?
Macrophages
1
1984
1460
0.010
Why?
Recombinant Proteins
1
2000
1281
0.010
Why?
Mice
1
1984
16602
0.000
Why?
Tail
1
1987
29
0.000
Why?
Phosphocreatine
1
1987
40
0.000
Why?
Salamandridae
1
1987
26
0.000
Why?
Animals
2
1987
34479
0.000
Why?
Aged
1
1984
21953
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
508
0.000
Why?
Adenosine Triphosphate
1
1987
471
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)